Ламберг-Н 50 мг/12,5 мг таблетки, покрытые пленочной оболочкой

Country: Kyrgyzstan

Language: Russian

Source: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Active ingredient:

Лозартан калия + Гидрохлортиазид

Available from:

Vegapharm LLP (Vegapharm LLP)

ATC code:

C09DA01

INN (International Name):

Losartan potassium + gidrokhlorisiazit

Dosage:

50 мг/12,5 мг

Pharmaceutical form:

таблетки, покрытые пленочной оболочкой

Units in package:

№30

Prescription type:

по рецепту

Manufactured by:

Akums Drugs & Pharmaceuticals Ltd (Индия)

Product summary:

ПЖВЛС: нет

Authorization date:

2019-03-05

Summary of Product characteristics

                                vTBEPII{AATO
3auecr
{euapraue
o6ecneqeHrrfl
u
[reA
Mnnucr
Krrp
nxaurcono3oBa
M.
"Od
"
A)ot
rrHCTPyKrl.rrfl
IIo
MEAL{qI,IHCKOMy
fIPI,IMEHEHI,IT
JIEKAPCTBEHHOI
O
TIPETIAPATA
JIAMBEPI--H
Topronoe
Ha3BaHrre
JIaru6epr-H
Mexayuap
oAH
o
e
H
errarelrro
B
aHH
o
e
H
arr
N{
eH
o
B
arrrr
e
Her
Jlemapcrneuuan
{opna
Ta6rerxr.r,
noKpE
rrbre
ureuo.ruoil
o6oro.{Koi.r
Cocran
KaN4aa
ra6nerra,
[oKpbrra.f,
nneno.rHoft
o6oloqxofr
,
coAepr(r.rr:
Axmueuute
seulecmco:
Jlosaprau
Kutus.
fu4poxnoporua3v1
50.00
ur
12.50
ur
B
c
nou
o
eomenb
Hu
e
c
elt4e
c
m6
a
:
MI,IKpOKpI{CTaJUIHTIeCKa,
rlennrcno3a,
JraKTO3a,
MHKpo
Kpr,rcrarJruqecKarr
qennronos
a
(pH-
I
0
2),
rtaruux
Ouucanne
Ta6lerxu,
[oKpbITbIe
nreuo'IHoft
o6oro.rKofi,
or
6eroro
Ao
noqru
6eroro
uBera,
Kpyrnbre,
ABo{KoBbr[yKJrbre,
uraAKrre
c
o6eux
cropoH.
@apuarcorepareBTr.rqecKafl
rpy[ra:
Aurarouucrbr
peqerrropoB
aHr]roreH3r4Ha
II
n
rou6n
HarJuu
c
.qr4yperr{Kaun.
JIos
aprau
s
xoN,r6
Lr*arryru
c
.quyp
err{KaMr.r.
Rod
ATX:
C09DA0I
@apuarcoloruqecxr{e
croilcrea
@apuaxodaHilMuKa
fr'ruorensraruoe
4eficrBlae
KoMIIoHeHToB
npeflapara
Jlau6epr-H
n
6olsurefi
crerreHr{
cHr4xaer
apTepl{aJlbHoe
AaBJIeHI{e,
qeM
KoMloHeHTbI
npenapaTa
no
oTAeJIbHocTr4.
Jlo:apran
-
.f,BJIteTC.[
CeJIeKTLIBHbIM
aHTafoHr,rcroM
peuenropoB
aHrr4oTeHgr.rHa
II
(runa
ATl)
aff
npI'IeMa
BHyrpb,
ne6emconofi
npupoArt.
In
vivo
u
in
vitro
no3apraH
ra
ero
6uororr4r{ecKu
arrusHHfi
xap6oxcumuuft
rrlera6olur
(EXP-3174)
lrcxupyror
ecq
SusuororHrrecKra
3Har{r4Mbre
s4ipexru
aHrl4oreH3l{ga
II
na
ATl-peqenroprl
He3aBI4cI4Mo
or
nyrr,I
ero
cHHTe3a:
npr,rBo.qur
K
rroBbrlrreHr,Iro
aKTLtBHOcrvt'
peHvrHa
rIJIa3Mbr
KpoBIc,
cHl4)r(aer
KoHrleHTparlurc
ilrbAocrepoHa
B
rrJra3Me
KpoBr{
IC
Ap.
Jlosaptau
KocBeHHo
BEI3bIBaer
aKTzBarIVlo
AT2-piqenropoB
3a
cqer
roBbrrrreHu,
ypoBH,
aHrI4oreH3I'IHa
II.
Jlosaprau
He
[oAaBr.aer
axTr.rBHocrb
KraHraHa3br
II,
Sepuenra,
xoropsrfi
yqacrByer
s
N'Iera6oJrI43Me
6paguxuuIzHa.
CHprNaer
o6u1ee
uepu$epuvecKoe
cocy.{}rcroe
corlporllBneHlle
(OIICC),
TaBJIeHI're
B
(MaJIoM)
Kpyre
npo"ooOpuuleHr{r;
yMeHbrxaer
nocrHarpy3Ky'
oKa3blBae
                                
                                Read the complete document
                                
                            

Documents in other languages